MORGAN FELDKAMP: Open Payments
NPI 1730964453 · HOISINGTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 14 payments from 7 companies in 2025. Trend: 2023 $43 · 2024 $312 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $69 |
| Lilly USA, LLC | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Biogen, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, LEQVIO, JARDIANCE, SKYCLARYS, NURTEC ODT, MOUNJARO, BEXSERO, Wegovy.
Industry payments across KS — which companies pay providers there.
